Article

Topical agents or dressings for pain in venous leg ulcers

School of Healthcare, University of Leeds, Baines Wing, Leeds, UK, LS2 9JT.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.7). 11/2012; DOI: 10.1002/14651858.CD001177.pub3

ABSTRACT BACKGROUND: Venous leg ulcers affect up to 1% of people at some time in their lives and are often painful. The main treatments are compression bandages and dressings. Topical treatments to reduce pain during and between dressing changes are sometimes used. OBJECTIVES: To determine the effects of topical agents or dressings for pain in venous leg ulcers. SEARCH METHODS: For this third update the following databases were searched: Cochrane Wounds Group Specialised Register (searched 9 May 2012); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 4); Ovid MEDLINE (2009 to April Week 4 2012); Ovid MEDLINE (In-Process & Other Non-Indexed Citations May 08, 2012); Ovid EMBASE (2009 to 2012 Week 18); and EBSCO CINAHL (2009 to May 2 2012). No date or language restrictions were applied. SELECTION CRITERIA: Published or unpublished randomised controlled trials (RCTs) that evaluated the effects of topical agents or dressing for the treatment of pain in venous ulcers were included. DATA COLLECTION AND ANALYSIS: Two review authors independently performed trial selection, data extraction and risk of bias assessment. MAIN RESULTS: Six trials (343 participants) evaluated Eutectic Mixture of Local Anaesthetics (EMLA): lidocaine-prilocaine cream for the pain associated with ulcer debridement. The between-group difference in pain measured on a 100 mm scale was statistically significant in favour of EMLA (MD -20.65, 95% CI -12.19 to -29.11). No significant between-group differences in burning or itching were observed.Two trials (470 participants with venous leg ulcers) evaluated ibuprofen slow-release foam dressings for persistent venous leg ulcer pain. Compared with local best practice, significantly more participants in the ibuprofen dressing group achieved the outcome of >50% of the total maximum pain relief score between day 1 and day 5 than participants in the local best practice group (RR 1.63, 95% CI 1.24 to 2.15). The number needed to treat was 6 (95% CI 4 to 12). In the second trial, compared with an identical non-ibuprofen foam dressing, there was no statistically significant difference in the proportion of participants experiencing slight to complete pain relief on the first evening of treatment.Limited data were available to assess healing rates or adverse events. AUTHORS' CONCLUSIONS: There is some evidence to suggest that ibuprofen dressings may offer pain relief to people with painful venous leg ulcers. EMLA (5%) appears to provide effective pain relief during the debridement of venous leg ulcers. Further research should consider standardised pain assessment methods and assess both the effect on ulcer healing and the impact of long term use of these treatments.

2 Followers
 · 
86 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Venous ulceration is the most severe and debilitating outcome of chronic venous insufficiency in the lower limbs and accounts for 80 percent of lower extremity ulcerations. The morbidity caused by them has a serious impact on the qual-ity of life. Sustained venous hypertension, caused by venous insufficiency leads to venous ulceration. The diagnosis is mainly clinical but needs to be differentiated from other causes of lower limb ulcers. Doppler ultrasound is the diagnos-tic investigation. Treatment options for venous ulcers include conservative management, mechanical treatment, medica-tions, and surgical options. The goals of treatment are to reduce edema, improve ulcer healing, and prevent recurrence. The achievement of good long term results depends on continuous care, ulcer care clinics, home health nursing and regular evaluation by the doctor. They have a crucial role to play for the amelioration of this common and morbid con-dition.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Venous ulceration is the most severe and debilitating outcome of chronic venous insufficiency in the lower limbs and accounts for 80 percent of lower extremity ulcerations. The morbidity caused by them has a serious impact on the qual-ity of life. Sustained venous hypertension, caused by venous insufficiency leads to venous ulceration. The diagnosis is mainly clinical but needs to be differentiated from other causes of lower limb ulcers. Doppler ultrasound is the diagnos-tic investigation. Treatment options for venous ulcers include conservative management, mechanical treatment, medica-tions, and surgical options. The goals of treatment are to reduce edema, improve ulcer healing, and prevent recurrence. The achievement of good long term results depends on continuous care, ulcer care clinics, home health nursing and regular evaluation by the doctor. They have a crucial role to play for the amelioration of this common and morbid con-dition.
    Surgical Science 01/2013; 04(02). DOI:10.4236/ss.2013.42028
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic leg ulcers affect approximately 1 – 3% of the population aged over 60 years in the U.K., Europe, U.S.A. and Australia (Briggs & Closs, 2003; Margolis et al., 2002). Prevalence increases with age (Margolis et al., 2002), rising from around 0.6% of the general adult population up to 2% - 5.6% of those aged over 65 years (Bergqvist et al., 1999). With today’s ageing societies (Parker, 2005), this condition will become an increasing problem in the future. Leg ulcers often take months or years to heal and frequently recur, becoming a life long chronic condition associated with prolonged ill-health, pain, restricted mobility and decreased quality of life (Chase et al., 2000; Walshe, 1995). When planning care for people with chronic leg ulcers, a health care model is required which not only addresses the need for evidence based wound care, but also pain management, symptom management and quality of life issues associated with the condition. Prevalence of pain associated with leg ulcers is reported as ranging from around 50% (Nemeth et al., 2003) to 80% (Hareendran, 2005) and leg ulcer pain is reported to decrease energy levels (Persoon et al., 2004), interrupt sleep (Edwards et al., 2005a), affect mood (Edwards et al., 2005a) and restrict mobility (Brown, 2005) and ability to manage normal work (Edwards et al., 2005a). Mobility is often further constrained by the need to wear bulky, multilayered bandages, limiting the type of footwear and clothing able to be worn. Reduced mobility impacts on independence in activities of daily living and productivity. For example, Abbade et al. (2005) found 49.2% of patients had a functional disability impacting on daily activities and work and Persoon et al.’s (2004) review of 37 studies found restraints in work and leisure activities were one of the major limitations imposed by leg ulcers. Pain, limited mobility and embarrassment associated with leg ulcers often leads to social isolation (Ebbeskog & Ekman, 2001; Persoon et al., 2004). The combination of pain, restricted mobility and social isolation in turn contributes to a negative impact on psychological health (Ebbeskog & Ekman, 2001; Persoon et al., 2004); such as depression and anxiety (Jones et al., 2006). In addition, the long term nature of the disease can lead to uncertainty, disappointment, loss of hope, or despair (Ebbeskog & Ekman, 2001). Problems with poor understanding of the cause and treatment of the condition have been noted (Chase et al., 2000), leading to feelings of powerlessness, lack of ownership and apathy with regard to management strategies. Not surprisingly, measures of quality of life in people with chronic leg ulcers have generally found significantly lower quality of life scores than in the general population (Franks et al., 2003; Jull et al., 2004).